PACB Similar Chart Price Prediction
The price of PACB is predicted to go up -51.74%, based on the high correlation periods with BRBS. The similarity of these two price pattern on the periods is 92.14%.
PACB
BRBS
Down: -51.74%Similarity: 92.14%
PACB Revenue Forecast
PACB EPS Forecast
PACB FAQs
What is revenue forecast for next quarter？
PACB Analyst's Forecast
Sung Ji Nam
Scotiabank
Buy
Price Target
$7 → $6
Upside
+143.9%
Scotiabank lowered the firm's price target on PacBio to $6 from $7 and keeps an Outperform rating on the shares. The firm lowered its FY24 and FY25 revenue estimates following the company's Q3 update, the analyst tells investors. The firm's longer-term outlook for the company, however, remains intact, believing the company is highly differentiated and the recently accelerated pace of product innovations place the company in a good position for outsized growth.
David Westenberg
Piper Sandler
Hold
Price Target
$2 → $2.5
Upside
+1.63%